BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/8/2015 3:25:00 PM | Browse: 1019 | Download: 1934
 |
Received |
|
2014-11-24 08:43 |
|
Peer-Review Started |
|
2014-11-24 10:28 |
|
To Make the First Decision |
|
2014-12-11 20:18 |
|
Return for Revision |
|
2014-12-24 10:29 |
|
Revised |
|
2015-02-10 19:38 |
|
Second Decision |
|
2015-04-07 17:16 |
|
Accepted by Journal Editor-in-Chief |
|
2015-04-08 03:46 |
|
Accepted by Company Editor-in-Chief |
|
2015-04-09 16:57 |
|
Articles in Press |
|
2015-04-09 17:17 |
 |
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2015-06-01 18:16 |
|
Typeset the Manuscript |
|
2015-07-23 19:40 |
|
Publish the Manuscript Online |
|
2015-08-08 15:26 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Prospective Study |
| Article Title |
Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Arghavan Haj-sheykholeslami, Maryam Keshvari, Heidar Sharafi, Ali Pouryasin, Khalil Hemmati and Fatemeh Mohammadzadehparjikolaei |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Pooyesh Darou which is the local manufacturer of pegylated interferon alpha-2a in Iran (Pegaferon) |
|
|
| Corresponding Author |
Maryam Keshvari, MD, Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran 14665-1157, Iran. m.keshvari@ibto.ir |
| Key Words |
Chronic hepatitis C; Pegylated interferon; rs12979860; rs8099917; Sustained virologic response |
| Core Tip |
Chronic hepatitis C-infected Iranian patients treated with pegylated interferon and ribavirin showed relatively high rates of sustained virologic response. Treatment success was not influenced by hepatitis C virus genotype. However, comparison of treatment success with IFNL polymorphisms (also known as IL28B polymorphisms) using a logistic regression analysis revealed that the interferon-λ rs12979860 CC genotype was significantly associated with achieving sustained virologic response. |
| Publish Date |
2015-08-08 15:26 |
| Citation |
Haj-sheykholeslami A, Keshvari M, Sharafi H, Pouryasin A, Hemmati K, Mohammadzadehparjikolaei F. Interferon- polymorphisms and response to pegylated interferon in Iranian hepatitis C patients. World J Gastroenterol 2015; 21(29): 8935-8942 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i29/8935.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i29.8935 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
